GENMAB A/S revenue breakdown overview

GENMAB A/S revenue for the last year amounted to 21.53 B DKK, the most of which — 21.53 B DKK — came from its highest performing source at the moment, Antibody Therapeutics, the year earlier bringing 16.47 B DKK. The greatest contribution to the revenue figure was made by Denmark — last year it brought GENMAB A/S 19.78 B DKK, and the year before that — 16.05 B DKK.